Clinical trials data
Trail Making Test in dementia and Alzheimer's trials: 273 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names the Trail Making Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 273
- Name it in a primary outcome, 30%
- 83 of 273
Tests named in the same studies
- 1
Digit Span Test104 studies, 37 as a primary outcome
- 2
Verbal Fluency101 studies, 38 as a primary outcome
- 3
Verbal Learning99 studies, 47 as a primary outcome
- 4
Category Fluency71 studies, 27 as a primary outcome
- 5
Stroop Color-Word Test63 studies, 24 as a primary outcome
- 6
Symbol Coding51 studies, 22 as a primary outcome
- 7
Picture Naming Test50 studies, 20 as a primary outcome
- 8
Complex Figure Copy and Recall38 studies, 18 as a primary outcome
- 9
Short Story Recall35 studies, 18 as a primary outcome
- 10
Clock Drawing Task33 studies, 10 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 3 | 1 |
| 2006 | 3 | 1 |
| 2007 | 3 | 0 |
| 2008 | 3 | 1 |
| 2009 | 5 | 1 |
| 2010 | 9 | 3 |
| 2011 | 8 | 4 |
| 2012 | 8 | 3 |
| 2013 | 13 | 2 |
| 2014 | 7 | 0 |
| 2015 | 10 | 5 |
| 2016 | 8 | 0 |
| 2017 | 12 | 4 |
| 2018 | 11 | 5 |
| 2019 | 22 | 6 |
| 2020 | 12 | 5 |
| 2021 | 15 | 6 |
| 2022 | 26 | 9 |
| 2023 | 22 | 3 |
| 2024 | 23 | 7 |
| 2025 | 32 | 11 |
| 2026 | 17 | 5 |
Phases and study sizes
By phase
- Early phase 15 studies, 2 as a primary outcome
- Phase 14 studies, 1 as a primary outcome
- Phase 1/29 studies, 2 as a primary outcome
- Phase 238 studies, 10 as a primary outcome
- Phase 2/35 studies, 0 as a primary outcome
- Phase 311 studies, 2 as a primary outcome
- Phase 413 studies, 2 as a primary outcome
- Not applicable156 studies, 53 as a primary outcome
- Observational32 studies, 11 as a primary outcome
Participants per study
- Phase 255 median, 32 to 80
- Phase 3390 median, 220 to 1,107
- Phase 4160 median, 92 to 257
- Not applicable61 median, 34 to 141
- Observational250 median, 116 to 713
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 37 | 55 | 32 to 80 |
| Phase 3 | 11 | 390 | 220 to 1,107 |
| Phase 4 | 12 | 160 | 92 to 257 |
| Not applicable | 154 | 61 | 34 to 141 |
| Observational | 30 | 250 | 116 to 713 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day14 outcomes, 8 as a primary outcome
- Up to 4 weeks19 outcomes, 5 as a primary outcome
- 1 to 3 months66 outcomes, 22 as a primary outcome
- 3 to 6 months55 outcomes, 16 as a primary outcome
- 6 to 12 months61 outcomes, 13 as a primary outcome
- 1 to 2 years25 outcomes, 6 as a primary outcome
- Over 2 years23 outcomes, 7 as a primary outcome
- No duration given10 outcomes, 6 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
263 of the 273 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting55 studies, 18 as a primary outcome
- Not yet recruiting16 studies, 4 as a primary outcome
- Active, not recruiting14 studies, 5 as a primary outcome
- Completed122 studies, 36 as a primary outcome
- Stopped early21 studies, 6 as a primary outcome
- Status unknown45 studies, 14 as a primary outcome
What they test
- Behavioral68 studies, 31 as a primary outcome
- Drug74 studies, 18 as a primary outcome
- Device57 studies, 14 as a primary outcome
- Dietary supplement12 studies, 2 as a primary outcome
- Procedure10 studies, 3 as a primary outcome
- Diagnostic test4 studies, 2 as a primary outcome
- Biological6 studies, 0 as a primary outcome
- Radiation2 studies, 1 as a primary outcome
- Combination product1 studies, 1 as a primary outcome
- Genetic1 studies, 1 as a primary outcome
- Other66 studies, 21 as a primary outcome
- None given19 studies, 7 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States97 studies, 31 as a primary outcome
- China33 studies, 7 as a primary outcome
- Italy21 studies, 5 as a primary outcome
- France19 studies, 3 as a primary outcome
- Canada17 studies, 1 as a primary outcome
- Germany12 studies, 2 as a primary outcome
- United Kingdom12 studies, 4 as a primary outcome
- Australia10 studies, 2 as a primary outcome
- Spain10 studies, 4 as a primary outcome
- Norway8 studies, 2 as a primary outcome
- South Korea7 studies, 5 as a primary outcome
- Sweden7 studies, 2 as a primary outcome
36 countries in all. A study with sites in several counts in each; 16 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name the Trail Making Test: 73 of 122, 60%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name the Trail Making Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 23, 19% | 776, 10% |
| Results on ClinicalTrials.gov only | 16, 13% | 1,139, 14% |
| A results paper only | 34, 28% | 1,711, 22% |
| Neither | 49, 40% | 4,327, 54% |
The 273 studies
273 studies match. 83 name the Trail Making Test in a primary outcome. Median size 72 participants. Median time to the primary outcome: 4 months.
Loading 273 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 3 | 1 |
| 2006 | 3 | 1 |
| 2007 | 3 | 0 |
| 2008 | 3 | 1 |
| 2009 | 5 | 1 |
| 2010 | 9 | 3 |
| 2011 | 8 | 4 |
| 2012 | 8 | 3 |
| 2013 | 13 | 2 |
| 2014 | 7 | 0 |
| 2015 | 10 | 5 |
| 2016 | 8 | 0 |
| 2017 | 12 | 4 |
| 2018 | 11 | 5 |
| 2019 | 22 | 6 |
| 2020 | 12 | 5 |
| 2021 | 15 | 6 |
| 2022 | 26 | 9 |
| 2023 | 22 | 3 |
| 2024 | 23 | 7 |
| 2025 | 32 | 11 |
| 2026 | 17 | 5 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 33, other 240. Interventional 241, observational 32.
As a primary outcomeSecondary or other outcomeThe Trail Making Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07883148 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants52 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07856043 | Start2026 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Cardiovascular disease | Participants18 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07841145 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants68 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07839650 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07741071 | Start2026 | PhasePhase 2 | ConditionsDementia and Alzheimer's | Participants270 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07731334 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants384 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07717411 | Start2026 | PhasePhase 3 | ConditionsDementia and Alzheimer's | Participants1,600 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07700615 | Start2025 | PhasePhase 4 | ConditionsDementia and Alzheimer's | Participants120 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT07692542 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07667478 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07646054 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants1,200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07645638 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants33 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07642726 | Start2018 | PhaseObservational | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants276 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07629349 | Start2020 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07505784 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07413744 | Start2026 | PhasePhase 1 | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07402356 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment, Depression and bipolar disorder | Participants140 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07399418 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07392944 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07392723 | Start2025 | PhasePhase 2 | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07385937 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07375771 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07366346 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07272863 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Aging, frailty and exercise, Sleep and sleep disorders | Participants214 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use the Trail Making Test?
273 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 83 of them in a primary outcome: 16% of the condition's 1,673 studies with a cognitive outcome, against 14% of all of them. It is the test dementia and Alzheimer's trials name most.
Which tests do dementia and Alzheimer's trials use with the Trail Making Test?
The Digit Span Test (104 studies), Verbal Fluency (101 studies) and Verbal Learning (99 studies).
How many participants do phase 2 dementia and Alzheimer's trials that use the Trail Making Test enroll?
Half of the phase 2 studies that name it enroll 55 participants or fewer, and the middle half enroll 32 to 80. 37 of them give a size.
When do dementia and Alzheimer's trials measure the Trail Making Test?
Half of the primary outcomes that name the Trail Making Test are measured within 4 months of the start, and the middle half from 8 weeks to 12 months. 77 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use the Trail Making Test have reported results?
73 of the 122 completed studies that name it, 60%, have reported results: 39 posted them on ClinicalTrials.gov, 57 have a results paper linked to the registry record, and 23 did both. The other 49 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Trail Making Test A and Trail Making Test B as one test family, so this page counts their studies together.
Run the Trail Making Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.